Contact
- Opening hours : Monday to Friday, 9 a.m. to 4:30 p.m.
- Telephone : 02 31 45 51 67
- Mail: p.marazzi@baclesse.unicancer.fr
Unit missions
At the Centre François Baclesse, just over 1,700 labile blood products were transfused in 2019. These include red blood cells, platelets and plasma. To ensure optimum safety for transfusion patients, the Hemovigilance Unit works closely with the Etablissement Français du Sang and the Regional Hemovigilance Coordinators.
Hemovigilance Unit
Comprising a health executive in charge of hemovigilance, a corresponding hemovigilance doctor and his deputy, the role of the hemovigilance unit is to ensure the safety of the transfusion process, from the medical prescription to the patient's transfusion, and even afterwards. It works in three areas: the management and traceability of transfusion activities, the prevention of transfusion-related risks, and the training and ongoing information of healthcare professionals.
The haemovigilance unit also plays an active role in the Réseau Normand d'Hémovigilance (ReNoH).
Transfusion Safety and Hemovigilance Committee (CSTH)
The CSTH is made up of representatives of the various institutional players and the Centre François Baclesse. It guarantees the application of transfusion safety at the Centre François Baclesse, and meets twice a year. It oversees the implementation of hemovigilance rules and procedures laid down by law, and is responsible for coordinating hemovigilance actions undertaken within the healthcare establishment.
Hemovigilance Steering Committee
Made up of a nurse from each transfusion department and the haemovigilance unit, the steering committee meets once a month to identify and analyze any malfunctions encountered in the departments, and to draw up transfusion procedures and operating modes. It ensures that good transfusion practices are disseminated and applied within the healthcare departments.
The team
Research areas / Projects
- Finalize the computerization of transfusion records: computerized receipt of test results from EFS (blood groups and RAI), computerized dispatch of labile blood product prescriptions.
- Personalized blood management: a patient-centered approach to reducing the risks associated with anemia, bleeding and transfusion, developed jointly with all doctors at the Centre François Baclesse.
- Continuing paramedical training: transfusion training program, including healthcare simulation modules.
Training courses
- Initial training: intern training at the beginning of each semester.
- Continuing education :
- training for every new nurse at the Centre François Baclesse.
- Medical transfusion newsletter, monthly hemovigilance newsflash for nurses.